/Companies

Foxo Technologies

OTC: FOXO

Minneapolis, US · Founded 2020 · 1 known investors

Find your way into Foxo Technologies

Sign up to see every warm intro you have to Foxo Technologies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Foxo Technologies team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

FOXO Technologies is a healthcare services and technology company operating three divisions: epigenetic diagnostics and interpretation, rural hospitals, and mental and behavioral health facilities. Each division is run through wholly owned subsidiaries.

Founders & leadership

Foxo Technologies was founded in 2020 by Jon Sabes and Steve Sabes.

JS
Jon SabesCo-founder
SS
Steve SabesCo-founder
MW
Martin WardInterim Chief Financial Officer
MW
Mark WhiteInterim Chief Executive Officer
BC
Brian ChenChief Science Officer
TD
Tyler DanielsonInterim Chief Executive Officer and Chief Technology Officer
LB
Lyle BermanNamed on SEC filing
RP
Robby PotashnickNamed on SEC filing
MW
Michael WillNamed on SEC filing
LZ
Laurence ZipkinNamed on SEC filing
AJ
Andrew J. PooleNamed on SEC filing
MK
Murdoc KhaleghiNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$25.1M disclosed across 29 rounds · 2021–2025

▶$3.5MraisedOct 2025 · 2 investors · Hospitals and Physicians
Rule 506(b)
Officers, directors & promoters on the filing
  • Sylwia Nowak HaumanExecutive Officer
  • Francis Colt deWolf IIIDirector
  • Mark WhiteDirector
  • Bret BarnesDirector
  • Seamus LaganExecutive Officer, Director
  • Trevor LangleyDirector
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$1.6MraisedJun 2025 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Seamus LaganExecutive Officer, Director
  • Bret BarnesDirector
  • Francis Colt deWolf IIIDirector
  • Trevor LangleyDirector
  • Mark WhiteDirector
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Jun 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$550KraisedJun 2025 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Francis Colt deWolf IIIDirector
  • Mark WhiteDirector
  • Bret BarnesDirector
  • Trevor LangleyDirector
  • Seamus LaganExecutive Officer, Director
  • Martin WardExecutive Officer
Offering amount
$550K
Amount sold
$550K
First sale
May 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$550KraisedMay 2025 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Francis Colt deWolf IIIDirector
  • Seamus LaganExecutive Officer, Director
  • Trevor LangleyDirector
  • Martin WardExecutive Officer
  • Mark WhiteDirector
  • Bret BarnesDirector
Offering amount
$550K
Amount sold
$550K
First sale
May 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$275KraisedApr 2025 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark WhiteDirector
  • Seamus LaganExecutive Officer, Director
  • Bret BarnesDirector
  • Francis Colt deWolf IIIDirector
  • Trevor LangleyDirector
  • Martin WardExecutive Officer
Offering amount
$275K
Amount sold
$275K
First sale
Apr 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$325KraisedApr 2025 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin WardExecutive Officer
  • Mark WhiteDirector
  • Seamus LaganExecutive Officer, Director
  • Bret BarnesDirector
  • Trevor LangleyDirector
  • Francis Colt deWolf IIIDirector
Offering amount
$325K
Amount sold
$325K
First sale
Apr 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$110KraisedMar 2025 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark WhiteDirector
  • Francis Colt deWolf IIIDirector
  • Trevor LangleyDirector
  • Martin WardExecutive Officer
  • Seamus LaganExecutive Officer, Director
  • Bret BarnesDirector
Offering amount
$1.5M
Amount sold
$110K
Finders' fees
$15.4K
Placement agents
J.H Darbie & Co., Inc.
First sale
Mar 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$425.1KraisedMar 2025 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Bret BarnesDirector
  • Mark WhiteDirector
  • Martin WardExecutive Officer
  • Francis Colt deWolf IIIDirector
  • Seamus LaganExecutive Officer, Director
  • Trevor LangleyDirector
Offering amount
$1.6M
Amount sold
$425.1K
Finders' fees
$59.5K
Placement agents
J.H Darbie & Co., Inc.
First sale
Jan 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Foxo Technologies do?
FOXO Technologies is a healthcare services and technology company operating three divisions: epigenetic diagnostics and interpretation, rural hospitals, and mental and behavioral health facilities. Each division is run through wholly owned subsidiaries.
Who founded Foxo Technologies?
Foxo Technologies was founded by Jon Sabes, Steve Sabes in 2020.
Who are Foxo Technologies's investors?
Foxo Technologies's investors include Z21 Ventures.
How much funding has Foxo Technologies raised?
Foxo Technologies has disclosed $25.1M raised across 29 rounds.
Where is Foxo Technologies headquartered?
Foxo Technologies is headquartered in Minneapolis, US.